Neonatal death suspected to be from sepsis was found to be kernicterus with g6pd deficiency

Pediatrics

Volumn 132, Issue 6, 2013, Pages

  Christensen, Robert D ^a   Yaish, Hassan M ^b,c   Wiedmeier, Susan E ^b,d   Reading, N Scott ^e   Pysher, Theodore J ^f,g   Palmer, Cheryl Ann ^f,g   Prchal, Josef T ^e,f,g  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b Departments of Pediatrics   (United States)

^c Division of Hematology Oncology   (United States)

^d Division of Neonatology   (United States)

^e ARUP LABORATORIES   (United States)

^f Geisel School of Medicine at Dartmouth   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

G6PD; Hemolysis; Jaundice; Kernicterus; Mahidol mutation; Neonate

Indexed keywords

ADENINE; BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GUANINE;

APNEA; ARTICLE; AUTOPSY; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CASE REPORT; EXCHANGE BLOOD TRANSFUSION; G6PD GENE; GENE SEQUENCE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN CELL; HYPOTENSION; INFANT; KERNICTERUS; LISTLESSNESS; MALE; MICROBIOLOGICAL EXAMINATION; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; OPISTHOTONUS; PHOTOTHERAPY; POINT MUTATION; PRIORITY JOURNAL; REPEAT PROCEDURE; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FATALITY; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; NEWBORN; SEPSIS;

DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; KERNICTERUS; MALE; SEPSIS;

EID: 84890783510     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1030     Document Type: Article

References (22)

1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316
2. Maisels MJ. Neonatal hyperbilirubinemia and kernicterus: not gone but sometimes forgotten. Early Hum Dev. 2009;85(11):727-732
3. Flaherman VJ, Kuzniewicz MW, Escobar GJ, Newman TB. Total serum bilirubin exceeding exchange transfusion thresholds in the setting of universal screening. J Pediatr. 2012;160(5):796-800, e1
4. Christensen RD, Lambert DK, Henry E, et al. Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system. Blood Cells Mol Dis. 2013;50(2):105-109
5. Christensen RD, Yaish HM, Nussenzveig RH, et al. Acute kernicterus in a neonate with O/B blood group incompatibility compounded by a mutation in SLC4A1. Pediatrics. 2013;132 (2). Available at: www.pediatrics.org/cgi/ content/full/132/2/e531
6. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose- 6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42(3):267-278
7. Bhutani VK, Johnson L. Synopsis report from the pilot USA Kernicterus Registry. J Perinatol. 2009;29(suppl 1):S4-S7
8. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29(suppl 1):S25-S45
9. Prchal JT, Gregg XT. Red cell enzymes. Hematology (Am Soc Hematol Educ Program). 2005;1:19-23
10. Yaish HM, Niazi GA, al Shaalan M, Khan S, Ahmed GS. Increased incidence of hyperbilirubinaemia in "unchallenged" glucose- 6-phosphate dehydrogenase deficiency in term Saudi newborns. Ann Trop Paediatr. 1991;11(3):259-266
11. Kaplan M, Hammerman C, Vreman HJ, Stevenson DK, Beutler E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. J Pediatr. 2001;139(1):137-140
12. Matsuoka H, Wang J, Hirai M, et al. Glucose-6- phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G.A) is the most common variant in the Myanmar population. J Hum Genet. 2004;49(10):544-547
13. Iwai K, Hirono A, Matsuoka H, et al. Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia. Hum Genet. 2001;108(6):445-449
14. Louicharoen C, Patin E, Paul R, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science. 2009;326(5959):1546-1549
15. AlOtaibi SF, Blaser S, MacGregor DL. Neurological complications of kernicterus. Can J Neurol Sci. 2005;32(3):311-315
16. Hameed NN, Na' Ma AM, Vilms R, Bhutani VK. Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology. 2011;100(1):57-63
17. Manning D, Todd P, Maxwell M, Jane Platt M. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007;92(5):F342-F346
18. Rorke LB. Kernicterus. In: Golden JA, Harding BN, eds. Pathology & Genetics, Developmental Neuropathology. Basel, Switzerland: ISN Neuropath Press; 2004:206-208
19. Hansen TW. The role of phototherapy in the crash-cart approach to extreme neonatal jaundice. Semin Perinatol. 2011;35(3):171- 174
20. Kaplan M, Hammerman C. Glucose-6- phosphate dehydrogenase-deficient neonates: A potential cause for concern in North America. Pediatrics. 2000;106(6): 1478-1479
21. Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol. 2013;33(7):499-504
22. Kaplan M, Kaplan E, Hammerman C, et al. Post-phototherapy neonatal bilirubin rebound: A potential cause of significant hyperbilirubinaemia. Arch Dis Child. 2006;91(1):31-34